Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1

Sanam Loghavi; Naveen Pemmaraju; Rashmi Kanagal-Shamanna; Meenakshi Mehrotra; L. Jeffrey Medeiros; Raja Luthra; Pei Lin; Yang Huh; Hagop M. Kantarjian; Jorge E. Cortes; Srdan Verstovsek; Keyur P. Patel

doi:10.1182/blood-2015-03-632893

Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1

Sanam Loghavi, Naveen Pemmaraju, Rashmi Kanagal-Shamanna, Meenakshi Mehrotra, L. Jeffrey Medeiros, Raja Luthra, Pei Lin, Yang Huh, Hagop M. Kantarjian, Jorge E. Cortes, Srdan Verstovsek, Keyur P. Patel

Research output: Contribution to journal › Letter › peer-review

21 Scopus citations

Original language	English (US)
Pages (from-to)	3360-3363
Number of pages	4
Journal	Blood
Volume	125
Issue number	21
DOIs	https://doi.org/10.1182/blood-2015-03-632893
State	Published - 2015

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2015-03-632893

Cite this

Loghavi, S., Pemmaraju, N., Kanagal-Shamanna, R., Mehrotra, M., Medeiros, L. J., Luthra, R., Lin, P., Huh, Y., Kantarjian, H. M., Cortes, J. E., Verstovsek, S., & Patel, K. P. (2015). Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1. Blood, 125(21), 3360-3363. https://doi.org/10.1182/blood-2015-03-632893

Loghavi, S , Pemmaraju, N , Kanagal-Shamanna, R, Mehrotra, M, Medeiros, LJ , Luthra, R , Lin, P, Huh, Y, Kantarjian, HM, Cortes, JE, Verstovsek, S & Patel, KP 2015, 'Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1', Blood, vol. 125, no. 21, pp. 3360-3363. https://doi.org/10.1182/blood-2015-03-632893

@article{acfd79844f7e4ce69874d51b45e303f5,

title = "Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1",

author = "Sanam Loghavi and Naveen Pemmaraju and Rashmi Kanagal-Shamanna and Meenakshi Mehrotra and Medeiros, {L. Jeffrey} and Raja Luthra and Pei Lin and Yang Huh and Kantarjian, {Hagop M.} and Cortes, {Jorge E.} and Srdan Verstovsek and Patel, {Keyur P.}",

year = "2015",

doi = "10.1182/blood-2015-03-632893",

language = "English (US)",

volume = "125",

pages = "3360--3363",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "21",

}

TY - JOUR

T1 - Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1

AU - Loghavi, Sanam

AU - Pemmaraju, Naveen

AU - Kanagal-Shamanna, Rashmi

AU - Mehrotra, Meenakshi

AU - Medeiros, L. Jeffrey

AU - Luthra, Raja

AU - Lin, Pei

AU - Huh, Yang

AU - Kantarjian, Hagop M.

AU - Cortes, Jorge E.

AU - Verstovsek, Srdan

AU - Patel, Keyur P.

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84964694696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964694696&partnerID=8YFLogxK

U2 - 10.1182/blood-2015-03-632893

DO - 10.1182/blood-2015-03-632893

M3 - Letter

C2 - 25999449

AN - SCOPUS:84964694696

SN - 0006-4971

VL - 125

SP - 3360

EP - 3363

JO - Blood

JF - Blood

IS - 21

ER -

Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this